Carbetapentane citrate 6 mg/mL / guaiFENesin 40 mg/mL / phenylephrine hydrochloride 1.6 mg/mL Oral Solution
RxNorm 1101738
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1101738 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane citrate 6 mg/mL / guaiFENesin 40 mg/mL / phenylephrine hydrochloride 1.6 mg/mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbetapentane citrate 6 mg/ML / guaifenesin 40 mg/ML / phenylephrine hydrochloride 1.6 mg/ML Oral Solution
(Atom ID: 12344271)
SY
Synonym (SY):
Carbetapentane citrate 30 mg / guaifenesin 200 mg / phenylephrine hydrochloride 8 mg per 5 mL Oral Solution
(Atom ID: 3717181)
TMSY
Tall Man Lettering Synonym (TMSY):
Carbetapentane citrate 30 mg / guaiFENesin 200 mg / phenylephrine hydrochloride 8 mg per 5 mL Oral Solution
(Atom ID: 3734299)
PSN
Prescribable Name (PSN):
Carbetapentane citrate 6 mg/mL / guaiFENesin 40 mg/mL / phenylephrine hydrochloride 1.6 mg/mL Oral Solution
(Atom ID: 12517220)
TMSY